Entries by akesogenadmin

AKESOgen and Identitas Partner

    AKESOgen and Identitas partner to provide a comprehensive Next Generation Forensic profiling solution   New York, NY, USA and Norcross, GA, USA – August 16th 2013 – Identitas Corp., a leader in forensic phenotyping and AKESOgen, the genomics and biorepository services company today announced a global commercial partnership to offer the forensic industry […]

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen Scientists Attend the 2013 BIO International Convention

AKESOgen scientists attended the 2013 BIO International Convention and were located at the Georgia Pavillion in Chicago April 22nd-25th 2013. Please email info@akesogen.com or call +1(770)542-0890 if you would like to follow up with a delegate to discuss your project or any biobanking or genomics needs.   Share this

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen completes 25,000 Nucleic Acid extractions in 18 months

AKESOgen completes 25,000 Nucleic Acid extractions in 18 months. “We are delighted to announce this important milestone in our DNA and RNA extraction services. During this time we have isolated, quantified and normalized DNA and RNA from sources as diverse as saliva, whole blood, buffy coat, buccal cells and paraffin embedded formalin fixed tissue for […]

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

Dr. Bouzyk Presents at the Clinical Business Expo Summit

Dr. Bouzyk presented at the Clinical Business Expo Summit at the Seaport World Trade Center, Boston, MA on September 18th 2012. Workshop entitled:Crucial Considerations to Guarantee Fit for Purpose and Project-Relevant Outcomes from your Biosample Collection: A Case-Based Approach   Share this

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen and London Genetics International alliance to enhance drug development

    AKESOgen and London Genetics International alliance to enhance drug development through pharmacogenetics and related services Norcross, GA, US and London, UK – March 29th 2012 – AKESOgen, the genomics and biorepository services company, and London Genetics International, an expert in the use of pharmacogenetics in drug discovery and development, today announced a strategic […]

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial. Regan MM, Leyland-Jones B, Bouzyk M, Pagani O, Tang W, Kammler R, Dell’orto P, Biasi MO, Thürlimann B, Lyng MB, Ditzel HJ, Neven P, Debled M, Maibach R, Price KN, Gelber RD, Coates AS, Goldhirsch A, Rae […]

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail